Literature DB >> 21960933

Serologic markers of hepatic fibrosis.

Don C Rockey1.   

Abstract

Entities:  

Year:  2008        PMID： 21960933      PMCID： PMC3096105     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  6 in total

Review 1.  Noninvasive measures of liver fibrosis.

Authors:  Don C Rockey; D Montgomery Bissell
Journal:  Hepatology       Date:  2006-02       Impact factor: 17.425

Review 2.  Noninvasive assessment of liver fibrosis and portal hypertension with transient elastography.

Authors:  Don C Rockey
Journal:  Gastroenterology       Date:  2008-01       Impact factor: 22.682

3.  Prospective comparison of six non-invasive scores for the diagnosis of liver fibrosis in chronic hepatitis C.

Authors:  Vincent Leroy; Marie-Noëlle Hilleret; Nathalie Sturm; Candice Trocme; Jean-Charles Renversez; Patrice Faure; Françoise Morel; Jean-Pierre Zarski
Journal:  J Hepatol       Date:  2007-01-26       Impact factor: 25.083

Review 4.  FibroTest and FibroScan for the prediction of hepatitis C-related fibrosis: a systematic review of diagnostic test accuracy.

Authors:  Abdel Aziz M Shaheen; Alex F Wan; Robert P Myers
Journal:  Am J Gastroenterol       Date:  2007-09-10       Impact factor: 10.864

5.  Correlation of FIBROSpect II with histologic and morphometric evaluation of liver fibrosis in chronic hepatitis C.

Authors:  Keyur Patel; David R Nelson; Don C Rockey; Nezam H Afdhal; Katie M Smith; Esther Oh; Keith Hettinger; Marc Vallée; Anouk Dev; Margaret Smith-Riggs; John G McHutchison
Journal:  Clin Gastroenterol Hepatol       Date:  2008-01-09       Impact factor: 11.382

6.  Meta-analyses of FibroTest diagnostic value in chronic liver disease.

Authors:  Thierry Poynard; Rachel Morra; Philippe Halfon; Laurent Castera; Vlad Ratziu; Françoise Imbert-Bismut; Sylvie Naveau; Dominique Thabut; Didier Lebrec; Fabien Zoulim; Marc Bourliere; Patrice Cacoub; Djamila Messous; Mona Munteanu; Victor de Ledinghen
Journal:  BMC Gastroenterol       Date:  2007-10-15       Impact factor: 3.067
  6 in total
  1 in total

1.  Egy-score predicts severe hepatic fibrosis and cirrhosis in Egyptians with chronic liver diseases: a pilot study.

Authors:  Mohamed A Alboraie; Mahmoud E Afifi; Fathy G Elghamry; Helmy A Shalaby; Gamal E Elshennawy; Ahmed A Abdelaziz; Mohamed U Shaheen; Amany R Abo El-Seoud
Journal:  Hepat Mon       Date:  2013-06-16       Impact factor: 0.660
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.